Collidion, Inc.
Collidion, Inc.

Collidion, Inc. Information

Contact top employees from Collidion, Inc.

Summary

Collidion, Inc. is a private company that has been in the industry for 11 years. The company currently specializes in the Pharmaceuticals area. The position of the Chairman & CEO is occupied by Hoji Alimi. Its headquarters is located at Petaluma, California, USA. The Collidion, Inc. annual revenue is estimated at < 1M. Total funding of the company - $24.5M. To connect with Collidion, Inc. employee register on SignalHire.

Organization Website

collidion.com

Social Links

linkedIn

Phone Number

707-668-7600

Industries

Headquarters Location

1770 Corporate Circle, Petaluma, California, 94954 US

Employees Size

10-50 employees

Specialties

partnering, drug development, clinical development, regulatory compliance, licensing, acquisition, funding innovation, capital raise, financing, healthcare

DMA Code

San Francisco Bay Area

Founded

2015

Operating Status

Independent Company

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Collidion, Inc. shows a diverse range of experience levels:
43% for 5–7 years57% for 8–10 years
Contact top employees from Collidion, Inc.

FAQ

Collidion, Inc. operates in the Pharma industries. More details can be found on the official website: collidion.com.
The headquarters of Collidion, Inc. are located in Petaluma, United States.
The current CEO of Collidion, Inc. is Hoji Alimi
You can contact Collidion, Inc. by phone at 707-668-7600.
Collidion, Inc. currently employs 10-50 people.
Collidion, Inc.'s revenue is approximately < 1M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP